Healthcare - Biotechnology - NASDAQ - US
$ 0.0003
0 %
$ 12.6 K
Market Cap
0.0
P/E
INCOME STATEMENT
0
REVENUE
-11.7 M
OPERATING INCOME
-11.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Scopus BioPharma Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 11.7 M |
| Operating Income | -11.7 M |
| Other Expenses | 0 |
| Net Income | -11.7 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 11.7 | 27.6 | 10.2 | 2.7 | 0.7 |
| Selling, General and Administrative Expenses | 9.0 | 12.6 | 2.7 | 2.2 | 0.4 |
| Research and Development Expenses | 2.7 | 15.0 | 7.4 | 0.5 | 0.3 |
| Operating Income | (11.7) | (27.6) | (10.2) | (2.7) | (0.7) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0.8 | 0.7 | 0 | 0 |
| Total Other Income | 0 | 0.7 | (0.7) | 0 | 0 |
| Pre-Tax Income | (11.7) | (27.0) | (10.9) | (2.7) | (0.7) |
| NET INCOME | |||||
| Tax Provision | (0.1) | 0.8 | 0.7 | 1 | (0.8) |
| Net Income | (11.6) | (27.7) | (11.6) | (2.7) | (0.7) |
| EPS | 0.55 | 1.61 | 0.87 | 0.18 | 0.0458 |